Search

New MSK research uncovers new details of the immune response against leptomeningeal metastasis; develops a grading system to assess the risk of developing thrombocytopenia after CAR T cell therapy; and outlines a method for scientists to estimate metabolic characteristics from challenging clinical samples.

… Monday, May 19, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) uncovers new details of the immune response against leptomeningeal metastasis; develops a grading system to assess the risk of developing thrombocytopenia after CAR T cell therapy; outlines a method for scientists to

Increased breast density, but not BMI, is an additional risk factor for breast cancer in women with lobular carcinoma in situ (LCIS).

… Thursday, January 30, 2020 Increased breast density was an additional risk factor for breast cancer in women with lobular carcinoma in situ (LCIS). However, body mass index (BMI) was not, according to our retrospective study published recently in the Annals of Surgical Oncology . Among a group of 1,222

Read up on the latest developments in several important areas of cancer research emerging from the 2019 American Association for Cancer Research annual meeting.

… Sunday, March 31, 2019 Summary Memorial Sloan Kettering researchers are featured in more than 150 abstracts and events at the 2019 American Association for Cancer Research annual meeting in Atlanta. Their scientific contributions are helping advance understanding of all aspects of cancer. Here’s a round-up

Learn about Louis Voigt, a critical care medicine specialist who is Chair of MSK's Ethics Committee.

… Thursday, November 29, 2018 Summary Critical care medicine specialist  Louis Voigt tells us about his background and philosophy of care, and explains the role of the Ethics Committee at MSK . How did you choose your specialty? Critical care came quite naturally to me both intellectually and emotionally

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April 14-19 in Orlando, Florida.

… Wednesday, April 12, 2023 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April

Fifth-year graduate student Semanti Mukherjee was awarded the Chairman's Prize for her first-author paper that was accepted for publication in the May 2011 issue of Human Heredity.

… Monday, August 1, 2011 Semanti Mukherjee, a fifth-year graduate student in Robert Klein’s lab in the Cancer Biology and Genetics Program, was awarded the Chairman’s Prize for her first-author paper  Including additional controls from public databases improves the power of a genome-wide association study

Learn more about Memorial Sloan Kettering’s newsletter for cancer survivors, which is celebrating its tenth year of publication.

… Thursday, June 21, 2018 Summary Bridges , Memorial Sloan Kettering’s newsletter for cancer survivors, is celebrating its tenth year of publication. Since its inception, Bridges has connected and inspired people who have faced cancer and the challenges that come with it. The quarterly publication is written

Learn about the role of radiation therapy in protecting women from breast cancer recurrence after breast-conserving surgery.

… Wednesday, June 3, 2020 Summary Radiation therapy given after breast-conserving surgery ( lumpectomy ) has proven effective at preventing the cancer from coming back. Learn more about different radiation therapy approaches for women with breast cancer and how to decide what is best for you. Women with

In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.

… Saturday, October 1, 2011 Summary In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid

While BRCA genes garner most of the public's attention, they're not the only cancer-predisposition genes doctors test for.

… Friday, October 18, 2019 Summary The science of clinical genetics is helping doctors understand more about the genes that increase a person’s risk of cancer, and which ones warrant genetic testing. When it comes to genes that predispose to cancer, most people have heard of BRCA1 and BRCA2 . Inherited